PATENT CLAIM ANALYSIS

Application Number: 15966436
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "489000"]

Abstract:
Embodiments of the disclosure relate generally to formulations, methods of treatment, kits, and dosage forms for treating inflammatory disorders, including atopic dermatitis, or cancer, the formulations comprising an active pharmaceutical ingredient. The formulation provided comprises granules, wherein the granules comprise: micronized active ingredient; one or more granulation binders; one or more fillers; one or more disintegrants; and one or more antioxidants. In one embodiment, the methods of treatment include orally administering the active ingredient to a subject suffering from atopic dermatitis, where the active ingredient is in an amount of about 20 mg to about 80 mg.

Claim (Index 49):
The method of  claim 47 , wherein the disease comprises one or more inflammatory disorders.

Metadata:
- Claim Count in Document: 78.0
- Percentile: 91.0
- Lexical Diversity: 1.78125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15909779', '14453129', '13491069', '12940808', '15060010']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.663025294963424
- 35 USC 102 Novelty (BERT): 0.5251166976238902
- Combined Prediction Score: 0.6492344352294706
- Mean Citation Score: 235.29096200000004
- Max Citation Score: 246.47133
- Similarity Product: 117.94293872500776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test